
Janssen Two-Drug HIV Treatment Receives Positive Results
Positive results from first phase III studies of investigational two-drug HIV treatment regimen. Janssen Sciences Ireland UC announced that two Phase III studies to evaluate the safety and efficacy of switching virologically suppressed patients from a three or four drug (integrase inhibitor-, non-nucleoside reverse transcriptase inhibitor-, or boosted protease inhibitor-based) antiretroviral regimen to the two…